LYRA   $0.24  4.35% Market Closed After Close 0.249 3.75%

Lyra Therapeutics Inc
Total Cash 67.50M
totalCashPerShare 1.031
EBITDA -74.33M
Total Debt 36.75M
quickRatio 3.502
currentRatio 3.602
Total Revenue 1.82M
debtToEquity 118.63
Revenue/Share 0.029
ROA -0.42356
ROE -1.56522
grossProfits
freeCashflow -40.52M
operatingCashflow -75.61M
earningsGrowth
revenueGrowth 0.306
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -29.77425
profitMargins 0.0
enterpriseValue -15.80M
forwardPE -0.3239189
floatShares 41.71M
sharesOutstanding 65.46M
sharesShort 2.85M
sharesShortPriorMonth 2.96M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.59%
Short Ratio help_outline 4.28%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 0.473
Price To Book help_outline 0.51
earningsQuarterlyGrowth
netIncomeToCommon -101.39M
trailingEps -1.56%
forwardEps -0.74%
enterpriseToEbitda 0.21
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.23 3Q 2024
institutionsCount 72
lastUpdated Oct. 16, 2024, 9:46 p.m.